Much of the U.S. drug supply is manufactured overseas, and the Food and Drug Administration inspects drug manufacturing facilities around the world to ensure that their drugs are safe for the U.S. market. How effective are these inspections?

Listen to Marcia Crosse, a director in our Health Care team, discuss her team’s recent review of FDA’s oversight of foreign drugs.

• Comments on GAO’s WatchBlog? Contact blog@gao.gov.